This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Ferenc Pusztai: Innovator in Liver Disease Treatment
Introduction
Ferenc Pusztai is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of liver diseases. His innovative work has led to the development of novel compounds that hold promise for therapeutic applications.
Latest Patents
Pusztai holds a patent for "Thiazolidinecarboxylic acid derivatives and treatment of liver diseases." This invention relates to novel thiazolidine-4(S)-carboxylic acid derivatives characterized by a general formula that includes various substituents. The compounds are designed to target liver diseases effectively, showcasing Pusztai's commitment to advancing medical science.
Career Highlights
Throughout his career, Ferenc Pusztai has been associated with Biogal Gyogyszergyar, a company dedicated to pharmaceutical development. His work at Biogal has allowed him to focus on innovative solutions for complex health issues, particularly those affecting liver function.
Collaborations
Pusztai has collaborated with several professionals in his field, including Zoltan Gyorgydeak and Istvan Kovacs. These partnerships have fostered a collaborative environment that enhances research and development efforts in medicinal chemistry.
Conclusion
Ferenc Pusztai's contributions to the field of liver disease treatment through his patented innovations highlight his role as a key figure in medicinal chemistry. His work continues to inspire advancements in therapeutic solutions for liver-related health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile